Investors & Media

Press Releases

Press Releases

Date Title View
September 6, 2023 Sage Therapeutics to Present at Upcoming September Investor Conferences
August 31, 2023 Sage Therapeutics Implements Strategic Reorganization to Support Plans for ZURZUVAE™ Commercial Launch and Pipeline Advancement
August 7, 2023 Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
August 4, 2023 Sage Therapeutics to Host Business Update Webcast and Announce Second Quarter Financial Results on Monday, August 7, 2023
August 4, 2023 FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder
June 5, 2023 Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
May 3, 2023 Sage Therapeutics to Present at Upcoming May Investor Conferences
May 2, 2023 Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
April 18, 2023 Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023
March 22, 2023 Sage Therapeutics to Present at the Stifel 2023 CNS Days
Displaying 1 - 10 of 19